Tuberculosis Market Research Reports & Industry Analysis
The Mantoux test is used in the United States and is endorsed by the American Thoracic Society and Centers for Disease Control and Prevention (CDC). Multiple puncture tests such as the Tine test are not recommended. The Mantoux test is one of the two major tuberculin skin tests for tuberculosis used in the world.
As a replacement for the Mantoux test, several other tests are being developed. QuantiFERON®-TB Gold, manufactured by Cellestis Limited (Carnegie, Victoria, Australia) is a blood test that measures the patient’s immune reactivity to the M. tuberculosis and is useful for initial and serial testing of persons with an increased risk of latent or active tuberculosis infection. Guidelines for the use of QuantiFERON-®TB Gold were released by the CDC in December of 2005. QuantiFERON®-TB Gold is FDA approved in the United States; has CE Mark approval in Europe; and has been approved by the MHLW in Japan. Sputum smears and cultures should be done for acid-fast bacilli if the patient is producing sputum. The preferred method for this is fluorescence microscopy (auramine-rhodamine staining), which is more sensitive than conventional Ziehl- Neelsen staining.
Tuberculosis Industry Research & Market Reports
-
ASEAN Point of Care Diagnostics Market by Product (Infectious Disease (TB, Hepatitis, STDs, HAIs), Glucose, Cardiometabolic, Pregnancy, Coagulation), Technology (Lateral Flow Assays, Biochemistry, MDx), End User (Home Care, Hospitals) - Forecast to 2030
... policies and funding investments drive the demand for Point of Care (POC) testing in the ASEAN region. Governments in these countries are increasingly supporting adopting such technologies to improve health access, reduce costs, and enhance ... Read More
-
Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035
... Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, ... Read More
-
Cancer Cachexia Market Report by Therapeutics (Progestogens, Corticosteroids, Combination Therapy, and Others), Mode of Action (Appetite Stimulators, Weight Loss Stabilizers), Distribution Channel (Hospital Stores, Retail Pharmacy, Online Pharmacy), and Region 2025-2033
... The market is driven by the rising global cancer incidence, the growing recognition of cachexia's significant impact on patient outcomes, and increased research into targeted therapies, all of which aim to enhance patient quality of ... Read More
-
Tuberculosis Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... is expected to expand from a value of US$2.44 billion in 2025 to US$3.76 billion by 2032, registering a compound annual growth rate (CAGR) of 6.35% during the forecast period. The market is being shaped ... Read More
-
Tuberculosis Testing
... CAGR of 4.9% over the analysis period 2024-2030. Hospitals, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.4 Billion by the end of the analysis period. ... Read More
-
Tuberculosis Therapeutics
... CAGR of 2.7% over the analysis period 2024-2030. Active TB, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$654.3 Million by the end of the analysis ... Read More
-
Infectious Disease Diagnostics
... at a CAGR of 5.5% over the analysis period 2024-2030. Assays & Reagents, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$25.8 Billion by the end ... Read More
-
Tuberculosis - Global Clinical Trials Review, 2025
... the clinical trials on Tuberculosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 ... Read More
-
Bacterial Vaccines Market, By Vaccine Type (Pertussis (Whooping Cough) Vaccines, Tetanus Vaccines, Diphtheria Vaccines, Pneumococcal Vaccines, Meningococcal Vaccines, Typhoid Vaccines, Tuberculosis (TB) Vaccines, Cholera Vaccines, Shigellosis Vaccines, and Others), By Patient Age Group (Pediatric Vaccines (Infants, Children), Adolescent Vaccines, Adult Vaccines, and Geriatric Vaccines), By Route of Administration (Intramuscular, Intravenous, Subcutaneous, and Others), By Distribution Channel (Public and Private), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... programs are carried out by governments and non-governmental organizations to spread awareness about the benefits of the preventive medicines including vaccines against infectious diseases. Market Dynamics: Global bacterial vaccines market is expected to grow at ... Read More
-
Infectious Disease Molecular Diagnostics Market Size, Share, and Outlook, 2025 Report- By Product & Service (Reagents, Kits, Consumables, Instruments, Software & Services), By Type of Testing (Laboratory Testing, PoC Testing), By Technology (Immunodiagnostics, Polymerase Chain Reaction, Clinical Microbiology, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-generation Sequencing, DNA Microarray, Others), By Disease Type (Hepatitis, HIV, Hospital-acquired Infections, Mosquito-borne Diseases, HPV, Chlamydia trachomatis, Neisseria gonorrhea, Tuberculosis, Influenza, Syphilis, Others), By Sample Type (Blood, Serum, and Plasma, Urine, Others), By End-User (Diagnostic Laboratories, Hospitals & Clinics, Academic Research Institutes, Others), 2021-2032
... business that is poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Infectious Disease Molecular Diagnostics ... Read More
-
Tuberculosis Diagnostics Global Market Report 2025
... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Anti-Tuberculosis Therapeutics Market Report by Disease Type (Active TB, Latent TB, and Others), Diagnosis and Treatment (Diagnosis, Treatment), End User (Hospitals, Specialty Clinics, Homecare, and Others), and Region 2025-2033
... The rising healthcare spending, favorable reimbursement policies, technological advancements, and growing public-private partnerships represent some of the key factors driving the market. Anti-tuberculosis therapeutics refer to the drugs and treatment strategies used to manage tuberculosis ... Read More
-
Respiratory Diagnostics Market Report by Product and Service Type (Instruments and Services, Assays and Reagents, Services and Software), Test Type (Mechanical Tests, Obstructive Sleep Apnoea (OSA) Diagnostic Tests, Imaging Tests, Traditional Diagnostic Tests, Molecular Diagnostic Tests, and Others), Disease (Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease (COPD), Lung Cancer, and Others), End-User (Hospitals, Clinics, Reference and Clinical Laboratories, and Others), and Region 2025-2033
... The growing prevalence of respiratory diseases, rising healthcare expenditure, increasing aging population, and heightened demand for early and accurate diagnosis to improve patient outcomes and manage chronic conditions effectively are some of the factors impelling ... Read More
-
Respiratory Diagnostics Market by Product & Services (Instrument & Devices), Test type (Mechanical, OSA, Imaging, Molecular Test), Disease (Tuberculosis, COPD, Lung Cancer ) and Diagnosis Type (Syndromic, Aetiological, Prognosis) - Global Forecast to 2030
... by many rising impacts with respect to improving cases of respiratory diseases around the world. Innovative technologies in diagnosis, such as molecular diagnostics and advanced imaging solutions, have also improved the accuracy and speed of ... Read More
-
Global Latent TB Testing Market (2025 Edition): Analysis By Test Type (Tuberculin Skin Test (TST), and Interferon Gamma Released Assay (IGRA)), By End User, By Region, By Country: Market Insights and Forecast (2020-2030)
... Test Type (Tuberculin Skin Test (TST), and Interferon Gamma Released Assay (IGRA)), By End User (Diagnostic Laboratories, Hospitals and Clinics, and Academic and Research Institute), for the historical period of 2020-2023, the estimates of 2024 ... Read More
-
2025 Global: Anti-Tuberculosis Drug Market - Innovative Markets Forecast (2031) report
... forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only market research ... Read More
-
Infectious Disease Diagnostic Testing: World Market Analysis, 2024-2029
... market trends is crucial for healthcare providers, investors, and industry stakeholders. This report offers a detailed analysis of the factors driving growth, including the increasing recognition of infectious diseases as a global health concern. As ... Read More
-
2024-2029 Tuberculosis Molecular Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... sale forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Tuberculosis tests performed in the following market segments: Hospitals - Commercial/Private ... Read More
-
Latent TB Testing Market by Test Type (Tuberculin Skin Test/TST, IGRA Test), Application (Household Contacts (HHC) of Tuberculosis (TB) Patients, People Living with HIV), End User (Diagnostic Labs, Hospitals), Region - Global Forecast to 2029
... The latent TB testing market will rise in value from estimated USD 582.5 million in 2024 to USD 773.4 million in 2029, at a CAGR of 5.8% over the forecast period. Increased funding and grants ... Read More
-
Tuberculosis Treatment Drugs Companies in China
... expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in ... Read More
-
Tuberculosis Treatment Drugs Markets in China
... Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's ... Read More
-
Tuberculosis Treatment Drugs Industry Forecasts - China Focus
... of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the ... Read More
-
TB Diagnostic Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 2025-2034. This report on global TB diagnostic market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global TB ... Read More
-
Tuberculosis Diagnostics Global Market Opportunities And Strategies To 2033
... Tests; Cell Culture-Based Tests2) By Disease Stage: Latent Tuberculosis; Active Tuberculosis3) By End User: Hospitals And Diagnostic Laboratories; Physician’s Office Laboratories; Reference Laboratories; Academics And Research FacilitiesCovering: Beckton, Dickinson and Company; Qiagen N.V.; F. Hoffmann-La ... Read More
-
2024 Global Tuberculosis Diagnostics Market: US, Europe, Japan - Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies
... US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Tuberculosis definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the ... Read More
Research Assistance
